MOHAPATRA SURYA Ndirector, officer: Chairman, President &..director, officer: Chairman, Pr..
Common Stock
50,000
$24.76
$1,238,000
Option
MILLER JOAN ELIZABETHofficer: SVP-Oncology & Neurology Sr..officer: SVP-Oncology & Neurolo..
Stock Options (Right to Buy)
19,259
$52.24
$1,005,994
Option
MILLER JOAN ELIZABETHofficer: SVP-Oncology & Neurology Sr..officer: SVP-Oncology & Neurolo..
Common Stock
19,259
$52.24
$1,005,994
Sale
MILLER JOAN ELIZABETHofficer: SVP-Oncology & Neurology Sr..officer: SVP-Oncology & Neurolo..
Common Stock
19,259
$52.24
$1,005,994
Option
ZIEGLER JOHN Bdirectordirector
Common Stock
12,997
$52.38
$680,796
Option
ZIEGLER JOHN Bdirectordirector
Stock Options (Right to Buy)
998
$52.69
$52,585
Option
MOHAPATRA SURYA Ndirector, officer: Chairman, President &..director, officer: Chairman, Pr..
Common Stock
50,000
$24.76
$1,238,000
Option
MOHAPATRA SURYA Ndirector, officer: Chairman, President &..director, officer: Chairman, Pr..
Stock Options (Right to Buy)
50,000
$24.76
$1,238,000
Sale
PREVOZNIK MICHAEL Eofficer: SVP & General Counselofficer: SVP & General Counsel
Common Stock
68,000
$35.53
$2,416,244
Option
PREVOZNIK MICHAEL Eofficer: SVP & General Counselofficer: SVP & General Counsel
Stock Options (Right to Buy)
68,000
$35.53
$2,416,244
Option
PREVOZNIK MICHAEL Eofficer: SVP & General Counselofficer: SVP & General Counsel
Common Stock
116,000
$46.11
$5,348,296
Option
MOHAPATRA SURYA Ndirector, officer: Chairman, President &..director, officer: Chairman, Pr..
Common Stock
48,047
$48.74
$2,341,811
Showing 550 to 600 of 1073 results.
Insider trading
Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.
Who is insider?
Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.